These findings are consistent with previous reports of ALI symptom attenuation mediated through inhibition of NLRP3 inflammasome activation (Zeng et al., 2023), which may account for the therapeutic effect of KAE in ALI. This evidence concerns the gene NLRP3 and acute respiratory distress syndrome.